The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease

作者: Abdulmaged M. Traish , Michael Zitzmann

DOI: 10.1007/S11154-015-9323-2

关键词:

摘要: Testosterone deficiency (TD) is a well-established and recognized medical condition that contributes to several co-morbidities, including metabolic syndrome, visceral obesity cardiovascular disease (CVD). More importantly, thought contribute TD. This complex bidirectional interplay between TD promotes vicious cycle, which further the adverse effects of may increase risk CVD. (T) therapy for men with has been shown be safe effective in ameliorating components syndrome (Met S) contributiong increased lean body mass reduced fat therefore weight loss. We believe appropriate T obese novel approach manage Indeed, other measures lifestyle behavioral changes can used augment but not fully replace this therapeutic approach. It should noted concerns regarding safety remain widely unsubstantiated considerable evidence exists supporting benefits therapy. Thus, it paramount clinicians managing made aware treatment obesity. In review, we discuss relationship highlight contemporary advancement management pharmacological surgical approaches, as well utilization how intervention may evolve .

参考文章(180)
Bernd Niemann, Ying Chen, Mirja Teschner, Ling Li, Rolf-Edgar Silber, Susanne Rohrbach, Obesity Induces Signs of Premature Cardiac Aging in Younger Patients Journal of the American College of Cardiology. ,vol. 57, pp. 577- 585 ,(2011) , 10.1016/J.JACC.2010.09.040
Wasana Pratchayasakul, Piangkwan Sa-nguanmoo, Sivaporn Sivasinprasasn, Hiranya Pintana, Rungroj Tawinvisan, Jirapas Sripetchwandee, Sirinart Kumfu, Nipon Chattipakorn, Siriporn C. Chattipakorn, Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Hormones and Behavior. ,vol. 72, pp. 68- 77 ,(2015) , 10.1016/J.YHBEH.2015.04.023
G. Corona, L. Vignozzi, A. Sforza, E. Mannucci, M. Maggi, Obesity and late-onset hypogonadism Molecular and Cellular Endocrinology. ,vol. 418, pp. 120- 133 ,(2015) , 10.1016/J.MCE.2015.06.031
Naomi E. Allen, Paul N. Appleby, Gwyneth K. Davey, Timothy J. Key, Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes & Control. ,vol. 13, pp. 353- 363 ,(2002) , 10.1023/A:1015238102830
Shehzad Basaria, Testosterone Levels for Evaluation of Androgen Deficiency JAMA. ,vol. 313, pp. 1749- 1750 ,(2015) , 10.1001/JAMA.2015.4179
Robert S. Tan, Kelly R. Cook, William G. Reilly, Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone International Journal of Endocrinology. ,vol. 2015, pp. 970750- 970750 ,(2015) , 10.1155/2015/970750
Andre B. Araujo, Gretchen R. Esche, Varant Kupelian, Amy B. O’Donnell, Thomas G. Travison, Rachel E. Williams, Richard V. Clark, John B. McKinlay, Prevalence of Symptomatic Androgen Deficiency in Men The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 4241- 4247 ,(2007) , 10.1210/JC.2007-1245
Leen Antonio, Frederick CW Wu, Terence W O'Neill, Stephen R Pye, Emma L Carter, Joseph D Finn, Martin K Rutter, Michaël R Laurent, Ilpo T Huhtaniemi, Thang S Han, Michael EJ Lean, Brian G Keevil, Neil Pendleton, Giulia Rastrelli, Gianni Forti, Gyorgy Bartfai, Felipe F Casanueva, Krzysztof Kula, Margus Punab, Aleksander Giwercman, Frank Claessens, Brigitte Decallonne, Dirk Vanderschueren, EMAS Study Group, None, Associations Between Sex Steroids and the Development of Metabolic Syndrome: A Longitudinal Study in European Men The Journal of Clinical Endocrinology and Metabolism. ,vol. 100, pp. 1396- 1404 ,(2015) , 10.1210/JC.2014-4184
Farid Saad, Antonio Aversa, Andrea M. Isidori, Louis J. Gooren, Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Current Diabetes Reviews. ,vol. 8, pp. 131- 143 ,(2012) , 10.2174/157339912799424573